 NEWARK, Calif., July 21, 2022 GLOBE NEWSWIRE -- Rain Therapeutics Inc. NasdaqGS: RAIN, Rain, a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter ended June 30, 2022 and highlights of recent progress on Thursday, August 4, 2022. On that day, management will host a conference call and webcast at 2:00 pm PT 5:00 pm ET to discuss the Companys business and financial results. 